These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12424506)
1. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. EL Desoky ES; Nagaraja NV; Derendorf H Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506 [TBL] [Abstract][Full Text] [Related]
2. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062 [TBL] [Abstract][Full Text] [Related]
4. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic investigation of digoxin in Japanese infants and young children. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416 [TBL] [Abstract][Full Text] [Related]
6. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis. Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of digoxin in pediatric patients. Martín-Suárez A; Falcao AC; Outeda M; Hernández FJ; González MC; Quero M; Arranz I; Lanao JM Ther Drug Monit; 2002 Dec; 24(6):742-5. PubMed ID: 12451291 [TBL] [Abstract][Full Text] [Related]
8. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants. Gong Y; Chen Y; Li Q; Li Z J Pharmacol Sci; 2014; 125(2):142-9. PubMed ID: 24837877 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of digoxin in elderly patients. Chen R; Zou SL; Wang ML; Jiang Y; Xue H; Qian CY; Xia ZL Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):115-21. PubMed ID: 23096939 [TBL] [Abstract][Full Text] [Related]
12. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure. Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482 [No Abstract] [Full Text] [Related]
13. Population pharmacokinetics of levosimendan in patients with congestive heart failure. Jonsson EN; Antila S; McFadyen L; Lehtonen L; Karlsson MO Br J Clin Pharmacol; 2003 Jun; 55(6):544-51. PubMed ID: 12814448 [TBL] [Abstract][Full Text] [Related]
14. Optimal digoxin concentrations for patients with heart failure. de Denus S; Spinler SA JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771103 [No Abstract] [Full Text] [Related]
15. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M Drugs Aging; 2011 Oct; 28(10):831-41. PubMed ID: 21970310 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic investigation of digoxin in Japanese neonates. Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Zhou XD; Gao Y; Guan Z; Li ZD; Li J Acta Pharmacol Sin; 2010 Jun; 31(6):753-8. PubMed ID: 20523346 [TBL] [Abstract][Full Text] [Related]
18. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure]. Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of digoxin in children with congestive heart failure aggravated by other diseases. Lares-Asseff I; Juárez-Olguín H; Flores-Pérez J; Bobadilla-Chávez J Rev Invest Clin; 2004; 56(1):32-7. PubMed ID: 15144040 [TBL] [Abstract][Full Text] [Related]
20. Effect of troglitazone on steady-state pharmacokinetics of digoxin. Loi CM; Knowlton PW; Stern R; Randinitis EJ; Vassos AB; Koup JR; Sedman AJ J Clin Pharmacol; 1998 Feb; 38(2):178-83. PubMed ID: 9549650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]